- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
48 Glioblastoma Trials near Chicago, IL
Power is an online platform that helps thousands of Glioblastoma patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerTriapine + Temozolomide for Brain Tumors
Trial Details
Key Eligibility Criteria
30 Participants Needed
Selinexor + Temozolomide for Recurrent Glioblastoma
Trial Details
Key Eligibility Criteria
97 Participants Needed
BDTX-1535 + Temozolomide for Glioblastoma and Lung Cancer
Trial Details
Key Eligibility Criteria
200 Participants Needed
Selinexor for Pediatric Solid Tumors or Brain Tumors
Trial Details
Key Eligibility Criteria
59 Participants Needed
TNG908 for Solid Tumors
Trial Details
Key Eligibility Criteria
192 Participants Needed
Intraoperative Radiotherapy for Glioblastoma
Trial Details
Key Eligibility Criteria
314 Participants Needed
Clindamycin + Triamcinolone for Glioblastoma Skin Side Effects
Trial Details
Key Eligibility Criteria
58 Participants Needed
Combination Immunotherapy for Glioblastoma
Trial Details
Key Eligibility Criteria
93 Participants Needed
LY3410738 for Solid Tumors
Trial Details
Key Eligibility Criteria
200 Participants Needed
Abemaciclib Combination Therapy for Neuroblastoma
Trial Details
Key Eligibility Criteria
117 Participants Needed
LP-184 for Solid Tumors
Trial Details
Key Eligibility Criteria
175 Participants Needed
ST101 for Advanced Cancer
Trial Details
Key Eligibility Criteria
125 Participants Needed
DSC-MRI for Recurrent Glioblastoma
Trial Details
Key Eligibility Criteria
146 Participants Needed
Multiple Therapies for Glioblastoma
Trial Details
Key Eligibility Criteria
1280 Participants Needed
Keto Diet vs Standard Cancer Diet for Glioblastoma
Trial Details
Key Eligibility Criteria
170 Participants Needed
Reduced-Dose Radiotherapy + Temozolomide for Glioblastoma
Trial Details
Key Eligibility Criteria
38 Participants Needed
Gallium Maltolate for Glioblastoma
Trial Details
Key Eligibility Criteria
36 Participants Needed
Olaparib for Advanced Cancer
Trial Details
Key Eligibility Criteria
89 Participants Needed
Why Other Patients Applied
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Glioblastoma clinical trials in Chicago, IL pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Glioblastoma clinical trials in Chicago, IL work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Glioblastoma trials in Chicago, IL 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Chicago, IL for Glioblastoma is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Chicago, IL several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Glioblastoma medical study in Chicago, IL?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Glioblastoma clinical trials in Chicago, IL?
Most recently, we added Lorlatinib for Brain Tumors, Olutasidenib + Temozolomide for Brain Tumors and Relatlimab + Nivolumab for Recurrent Glioblastoma to the Power online platform.